 | Up a level |
Boon, C. J. F., van Dijk, E. H. C., Fauser, S., Breukink, M. D., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., Querques, G., Downes, S. M. and Hoyng, C. B. (2018). The PLACE trial: an open-label, multicenter, randomized controlled trial comparing half-dose photodynamic therapy with subthreshold micropulse laser for chronic central serous chorioretinopathy. Acta Ophthalmol., 96. S. 31 - 32. HOBOKEN: WILEY. ISSN 1755-3768
Chung, W. H., van Dijk, E. H. C., Mohabati, D., Dijkman, G., Yzer, S., de Jong, E. K., Fauser, S., Schlingemann, R. O., Hoyng, C. B. and Boon, C. J. F. (2017). Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome. Acta Ophthalmol., 95. S. 23 - 24. HOBOKEN: WILEY. ISSN 1755-3768
Ersoy, L., Schick, T., de Graft, D., Felsch, M., Hoyng, C. B., den Hollander, A. I., Kirchhof, B., Fauser, S. and Liakopoulos, S. (2016). Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes. Br. J. Ophthalmol., 100 (8). S. 1047 - 1052. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2079
Mohabati, D., van Dijk, E. H. C., van Rijssen, T. J., de Jong, E. K., Breukink, M. B., Martinez-Ciriano, J. P., Dijkman, G., Hoyng, C. B., Fauser, S., Yzer, S. and Boon, C. J. F. (2017). Severe phenotypes of chronic central serous chorioretinopathy: clinical characteristics and response to photodynamic therapy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768
Schellevis, R. L., van Dijk, E. H. C., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., Boon, C. J. F. and de Jong, E. K. (2017). A genetic variant in the NR3C2 gene, encoding the mineralocorticoid receptor, is associated with chronic central serous chorioretinopathy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768
Schreur, V., Altay, L., van Asten, F., Groenewoud, J. J. M., Klevering, B. J., Hoyng, C. B. and de Jong, E. K. (2017). Hyperreflective foci predict treatment response to bevacizumab in patients with diabetic macular edema. Acta Ophthalmol., 95. S. 19 - 20. HOBOKEN: WILEY. ISSN 1755-3768
Schreur, V., Altay, L., van Asten, F., Groenewoud, J. M. M., Klevering, B. J., Hoyng, C. B. and de Jong, E. K. (2017). HYPERREFLECTIVE FOCI PREDICT TREATMENT RESPONSE TO BEVACIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA. Eur. J. Ophthalmol., 27 (3). S. E119 - 1. MILAN: WICHTIG PUBLISHING. ISSN 1724-6016
van Dijk, E. H. C., Hahn, L., van Rijssen, T. J., Scholz, P., Breukin, M. B., Souied, E. H., MacLaren, R. E., Querques, G., Fauser, S., Downes, S. M., Hoyng, C. B. and Boon, C. J. F. (2020). Pigment epithelial detachments in chronic central serous chorioretinopathy: Effect of half-dose photodynamic therapy versus high-density subthreshold micropulse laser PLACE trial report No. 5. Acta Ophthalmol., 98. S. 40 - 42. HOBOKEN: WILEY. ISSN 1755-3768
van de Ven, J. P. H., Nilsson, S. C., Tan, P. L., Buitendijk, G., Ristau, T., Mohlin, F. C., Nabuurs, S. B., Schoenmaker-Koller, F. E., Smailhodzic, D., Campochiarro, P. A., Zack, D. J., Duvvari, M. R., Bakker, B., Paun, C. C., Boon, C. J. F., Uitterlinden, A. G., Liakopoulos, S., Klevering, B. J., Fauser, S., Daha, M. R., Katsanis, N., Klaver, C. C. W., Blom, A. M., Hoyng, C. B. and den Hollander, A. I. (2013). A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Mol. Immunol., 56 (3). S. 247 - 249. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890